EcoDrugPlus

Ensembl ID : ENSLBEG00000005273
Gene Symbol: -
Cross references: -
4 Possible Orthologues:

Ensembl ID : ENSLBEG00000019303
Gene Symbol: -
Cross references: -
268 Possible Orthologues:

Ensembl ID : ENSLBEG00000012353
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSLBEG00000025969
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSLBEG00000018760
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSLBEG00000025826
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSLBEG00000000451
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSLBEG00000029020
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSLBEG00000001196
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSLBEG00000000225
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Ensembl ID : ENSLBEG00000026358
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSLBEG00000000175
Gene Symbol: -
Cross references: -
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).